Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market

Arcturus Therapeutics (ARCT) Stock Investors

1,133 Followers
Based on 687,379 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ARCT
On average, investors allocate 3.07% of their portfolios to ARCT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 687,379 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ARCT

4.8%
Last 7
Days
3.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ARCT, out of 687,379 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ARCT Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
2.43%
$32.15
Opened
2.09%
$25.99
Opened
0.47%
$36.65
Opened
0.00%
$25.93
Opened
1.43%
$31.56
Based on the activity of 12,705 investors who made their portfolios public
The table shows changes in ARCT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ARCT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.08%
+0.47%
-1.65%
38.06B
Healthcare
Coherus Biosciences
2.52%
-1.32%
+773.80%
492.72M
Healthcare
Roku
5.14%
-0.58%
-2.26%
8.60B
Technology
Block
4.20%
-0.11%
-0.30%
24.57B
Technology
Nikola
6.32%
+0.68%
-0.75%
1.07B
Energy
Micron
5.64%
+0.25%
-2.26%
75.44B
Technology
Blink Charging Co
4.22%
+0.81%
+2.27%
204.27M
Utilities
Trade Desk
5.00%
-0.80%
-2.52%
34.06B
Technology
Marvell
4.80%
+0.24%
+3.48%
45.12B
Technology
Salesforce
4.89%
-0.37%
+1.56%
200.86B
Technology
Based on the activity of 687,379 active portfolios
Open your Smart Portfolio

ARCT Investor Analysis

ARCT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.0%
of ARCT holders
are under 35
Average Segment Performance
Average P/E Ratio-28.27
Beta9.48
Dividend Yield5.31%
ARCT investors between 35–55

Between 35–55

1.6%
Last 30 days
Holdings Change
55.6%
of ARCT holders
are between 35–55
Average Segment Performance
Average P/E Ratio-25.67
Beta14.52
Dividend Yield18.48%
ARCT investors over 55

Over 55

5.5%
Last 30 days
Holdings Change
29.4%
of ARCT holders
are over 55
Average Segment Performance
Average P/E Ratio-18.77
Beta5.45
Dividend Yield5.10%
Overview of age group and performance of ARCT stock investors
See who invests in ARCT according to age group and performance.

FAQ

How many retail Investors hold ARCT?
<0.1% of TipRank’s retail investors hold ARCT in their portfolios.
    What is ARCT Investor Sentiment?
    ARCT’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of ARCT in the last 7 days?
      ▲ 4.8% of TipRank’s retail investors changed their holding of ARCT in the last 7 days.
        What percentage of retail investors changed their holding of ARCT in the last 30 days?
        ▲ 3.9% of TipRank’s retail investors changed their holding of ARCT in the last 30 days.
          What is the average age of retail investors who hold ARCT?
          The average age of ARCT Holders is between 35–55.
            What other stocks have ARCT investors also bought?
            ARCT Investors also bought MRNA, CHRS, ROKU, SQ, NKLA, MU, BLNK, TTD, MRVL, CRM.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AMRNAmarin
              BSXBoston Scientific
              CNCCentene
              CHRSCoherus Biosciences

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis